Punding and dyskinesias

Department of Neurology, Donauspital/Sozialmedizinisches Zentrum Ost, Vienna, Austria
Movement Disorders (Impact Factor: 5.63). 12/2006; 21(12):2214 - 2217. DOI: 10.1002/mds.21118

ABSTRACT The presence of punding in Parkinson's disease (PD) has been associated with inappropriate excessive use of dopaminergic medication but its relation to the severity of dyskinesias is not known. Through the use of clinical examination and medical chart review, the presence of punding and the severity of interdose dyskinesias were evaluated by two different observers. Punding was associated with more frequent interventions to reduce dyskinesias and with greater dyskinesia severity. We suggest the neural systems mediating the expression of dyskinesias and punding might overlap and that punding should be looked for systematically in PD patients presenting with disabling severe dyskinesias. © 2006 Movement Disorder Society

  • [Show abstract] [Hide abstract]
    ABSTRACT: A class of queueing network models with dynamic routing based on the principle of balanced load is proposed. The principle of dynamic routing considered is to select a server with the shortest queue among a sample collection of servers chosen at random.
    Information Theory, 2002. Proceedings. 2002 IEEE International Symposium on; 02/2002
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: A range of impulse control and repetitive behaviors presumed to be related to dopaminergic medications has been recognized in Parkinson's disease. These behaviors are linked by their incentive or reward-based and repetitive natures and overlap with addictions. The behaviors include pathological gambling, hypersexuality, compulsive shopping, and compulsive eating and are related to punding and compulsive medication use. In patients on dopamine agonists, these behaviors as a group are relatively common, can have potentially devastating psychosocial consequences and are commonly hidden. Recent studies have investigated prevalence rates and associated factors. The literature on these behaviors in Parkinson's disease, including definitions, epidemiology, pathophysiology and management, is reviewed. The relationship to medications, Parkinson's disease and individual susceptibility is examined. These behaviors can affect up to 14% of Parkinson's disease patients on dopamine agonists. Clinicians should warn patients prior to initiating dopamine agonists and enquire about these behaviors during follow up.
    Current Opinion in Neurology 09/2007; 20(4):484-92. DOI:10.1097/WCO.0b013e32826fbc8f · 5.73 Impact Factor
Show more